These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17182514)

  • 1. Equianalgesic dosing of opioids.
    Berdine HJ; Nesbit SA
    J Pain Palliat Care Pharmacother; 2006; 20(4):79-84. PubMed ID: 17182514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid conversions in acute care.
    Patanwala AE; Duby J; Waters D; Erstad BL
    Ann Pharmacother; 2007 Feb; 41(2):255-66. PubMed ID: 17299011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses.
    Svendsen K; Borchgrevink P; Fredheim O; Hamunen K; Mellbye A; Dale O
    Palliat Med; 2011 Oct; 25(7):725-32. PubMed ID: 21378066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
    Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
    Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid switching between transdermal fentanyl and methadone in cancer patients.
    Mercadante S; Ferrera P; Villari P; Casuccio A
    J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
    Zimmermann C; Seccareccia D; Booth CM; Cottrell W
    J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opioid switch and change of route of administration in cancer patients treated by morphine].
    Michenot N; Rostaing S; Baron L; Faure S; Jovenin N; Hubault P; Delorme T; Collin E; Filbet M; Chvetzoff G; Delorme C; Minello C; Magnet M; Ammar D; Krakowski I; Poulain P
    Bull Cancer; 2018 Nov; 105(11):1052-1073. PubMed ID: 30274680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an opioid taper algorithm in hematopoietic progenitor cell transplant recipients.
    Parran L; Pederson C
    Oncol Nurs Forum; 2002; 29(1):41-50. PubMed ID: 11817492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone treatment for pain states.
    Toombs JD; Kral LA
    Am Fam Physician; 2005 Apr; 71(7):1353-8. PubMed ID: 15832538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid equianalgesic conversion: the right dose.
    Brant JM
    Clin J Oncol Nurs; 2001; 5(4):163-5. PubMed ID: 12690618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone.
    LeBaron V; Brody J; Lee EM; Hardin C; Snyder L
    J Pain Palliat Care Pharmacother; 2011; 25(4):356-61. PubMed ID: 22126165
    [No Abstract]   [Full Text] [Related]  

  • 14. Equianalgesia: applying evidence-based practice guidelines.
    Bond BS
    Clin J Oncol Nurs; 2008 Jun; 12(3):527-9. PubMed ID: 18515253
    [No Abstract]   [Full Text] [Related]  

  • 15. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
    Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
    J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid equianalgesic tables: are they all equally dangerous?
    Shaheen PE; Walsh D; Lasheen W; Davis MP; Lagman RL
    J Pain Symptom Manage; 2009 Sep; 38(3):409-17. PubMed ID: 19735901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations.
    Manfredi PL; Borsook D; Chandler SW; Payne R
    Pain; 1997 Mar; 70(1):99-101. PubMed ID: 9106815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences.
    Ripamonti C; De Conno F; Groff L; Belzile M; Pereira J; Hanson J; Bruera E
    Ann Oncol; 1998 Jan; 9(1):79-83. PubMed ID: 9541687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid rotation for cancer pain: rationale and clinical aspects.
    Mercadante S
    Cancer; 1999 Nov; 86(9):1856-66. PubMed ID: 10547561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.